Headline
The latest news stories.
In this conversation, Kardie Tobb, D.O., a non-invasive preventative cardiologist at Cone Health, explains how multidisciplinary teams are breaking down clinical silos, emphasizing preconception care, and coordinating care across specialties to support healthier pregnancies and healthier families.
The Food and Drug Administration has approved a blood test for detecting Alzheimer’s by Roche and Eli Lilly, according to an announcement Aug. 24 by Roche.
The AHA Aug. 25 submitted comments to Sen. Bill Cassidy, R-La., on the 340B Drug Pricing Integrity and Affordability for Patients Act (340B for Patients Act), a legislative discussion draft that would make significant changes to the current structure and scope of the 340B program.
Two individuals in Pennsylvania have died from measles, the Pennsylvania Department of Health announced Aug. 25.
The AHA’s Association for the Health Care Environment will host a webinar Sept. 8 at 2 p.m. ET that will discuss strategies environmental services leaders can leverage to improve consistency and quality in environments with rapid microbial rebound.
Gabriela Jimenez Thompson, program lead of Our Story Begins at NYC Health + Hospitals/Bellevue, and Liliana Escobar, R.N., NICU head nurse at Bellevue Hospital Center, share how the Our Story Begins program uses books, reading, language and nurse education to strengthen NICU parent engagement,…
The Food and Drug Administration has issued early alerts for the following products.
Epic’s MyChart has shared examples from potential phishing schemes observed as recently this month that include email messages linking to a fake MyChart website displaying erroneous medical records and others notifying of a free “2026 Medicare Health Kit.”
The Department of Homeland Security today released a proposed rule to establish a new $103,265 filing fee for H-1B visa petitions that are subject to statutory numerical caps, including those eligible for the advanced degree exemption.
The Food and Drug Administration has identified a Class I recall of certain Medline convenience kits containing B. Braun components that have Huons Bupivacaine Hydrochloride in Dextrose Injection, which has also been recalled.